AND RELEVANCE TO CLINICAL PRACTICE
REFERENCES
14 CHAPTER 9: Acute Sarcopenia DEFINITION EPIDEMIOLOGY PATHOGENESIS OUTCOMES TREATMENT CONCLUSION REFERENCES
15 CHAPTER 10: Sarcopenia, Frailty, and Intrinsic Capacity INTRODUCING THE FRAILTY CONCEPT THE PHYSICAL PHENOTYPE ACCORDING TO FRIED AND THE DEFICIT MODEL ACCORDING TO ROCKWOOD SARCOPENIA AND FRAILTY – OVERLAP AND DIFFERENCES THE FUTURE RELEVANCE OF FRAILTY INTRINSIC CAPACITY REFERENCES
16 CHAPTER 11: Osteosarcopenia INTRODUCTION PATHOPHYSIOLOGY EPIDEMIOLOGY CLINICAL ASSESSMENT TREATMENTS SUMMARY REFERENCES
17 CHAPTER 12: Sarcopenic Obesity INTRODUCTION DEFINITION OF SARCOPENIC OBESITY PATHOGENESIS OF SO CLINICAL IMPLICATIONS TREATMENT CONCLUSION REFERENCES
18 CHAPTER 13: Sarcopenia and Cognitive Impairment INTRODUCTION AGING AND COGNITIVE DECLINES PHYSICAL AND COGNITIVE DECLINES SARCOPENIA AND COGNITIVE IMPAIRMENT CONCLUSIONS REFERENCES
19 CHAPTER 14: Sarcopenia and Other Chronic Organ Diseases CHRONIC OBSTRUCTIVE PULMONARY DISEASE CHRONIC KIDNEY DISEASE CHRONIC HEART FAILURE DIABETES MELLITUS RHEUMATOID ARTHRITIS (RA) CONCLUSIONS REFERENCES
20 CHAPTER 15: Imaging of Skeletal Muscle INTRODUCTION DUAL X‐RAY ABSORPTIOMETRY COMPUTED TOMOGRAPHY MAGNETIC RESONANCE IMAGING POSITRON EMISSION TOMOGRAPHY CONCLUSION REFERENCES
21 CHAPTER 16: Measurements of Muscle Mass: Equations and Cut‐off Points INTRODUCTION ANTHROPOMETRY – METHOD DESCRIPTION ANTHROPOMETRY – CUT‐OFF POINTS IN SARCOPENIA RESEARCH BIOELECTRICAL IMPEDANCE – METHOD DESCRIPTION BIOELECTRICAL IMPEDANCE – CUT‐OFF POINTS IN SARCOPENIA RESEARCH DXA – METHOD DESCRIPTION DXA – CUT‐OFF POINTS IN SARCOPENIA RESEARCH CT AND MRI – METHOD DESCRIPTION CT AND MRI – CUT‐OFF POINTS IN SARCOPENIA RESEARCH EMERGING METHODS OVERVIEW OF METHODS REFERENCES
22 CHAPTER 17: Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans: Methods, Early Results, and Future Directions INTRODUCTION METHODS AND OPERATIONAL APPROACH CONSIDERATION OF BODY SIZE IN ANALYSIS OF MUSCLE MASS SUMMARY
